Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer

Wu,Yumin; Yan,Yulan; Su,Zhaoliang; Bie,Qingli; Chen,Xiaobo; Barnie,Prince Amoah; Guo,Qi; Wang,Shengjun; Xu,Huaxi

doi:10.3892/mmr.2017.6537

Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer

Authors:
- Yumin Wu
- Yulan Yan
- Zhaoliang Su
- Qingli Bie
- Xiaobo Chen
- Prince Amoah Barnie
- Qi Guo
- Shengjun Wang
- Huaxi Xu
View Affiliations

Affiliations: Department of Immunology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China, Department of Pulmonology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China
Published online on: May 2, 2017 https://doi.org/10.3892/mmr.2017.6537
Pages: 4374-4381

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Group 2 innate lymphoid cells (ILC2s) were demonstrated to be involved in the initiation and coordination of type 2 T helper cell (Th2) responses. Myeloid‑derived suppressor cells (MDSCs) have received a great deal of attention for their role in creating an immunosuppressive microenvironment in cancer‑bearing hosts. However, the contributions of ILC2s in the occurrence and development of lung cancer, and the association between ILC2s and Th2 or MDSCs in lung cancer remain to be elucidated. In the present study, 36 patients newly diagnosed with lung cancer based on the guidelines of the International Union Against Cancer Tumor Node Metastasis were included. The frequencies of ILC2s and MDSCs in peripheral blood mononuclear cells were determined, and the mRNA expression levels of ILC2s or Th2‑related transcription factors and cytokines, and MDSCs‑related products were assessed. The results demonstrated that the frequencies of the circulatory ILC2s and MDSCs were enhanced in lung cancer patients, as were ILC2‑related transcription factors and cytokines in peripheral blood. A positive correlation was identified between the Th2‑dominated phenotype and the expression levels of ILC2s‑associated cytokines or transcription factors. In addition, increased autophagy related 1 was closely associated with Th2‑associated transcription factors. It was demonstrated that ILC2s and MDSCs were clearly upregulated and accompanied by a predominant Th2 phenotype in patients with lung cancer; this may lead to new immunotherapy approaches for lung cancer based on the associated metabolites and cytokines.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar
2	Danelli L, Frossi B and Pucillo CE: Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment. Oncoimmunology. 4:e10012322015. View Article : Google Scholar :
3	Basith S, Manavalan B, Yoo TH, Kim SG and Choi S: Roles of Toll-like receptors in cancer: A double-edged sword for defense and offense. Arch Pharmacal Res. 35:1297–1316. 2012. View Article : Google Scholar
4	Hoyler T, Klose CS, Souabni A, Turqueti-Neves A, Pfeifer D, Rawlins EL, Voehringer D, Busslinger M and Diefenbach A: The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity. 37:634–648. 2012. View Article : Google Scholar :
5	Roediger B and Weninger W: Group 2 innate lymphoid cells in the regulation of immune responses. Adv Immunol. 125:111–154. 2015. View Article : Google Scholar
6	Halim TY, MacLaren A, Romanish MT, Gold MJ, McNagny KM and Takei F: Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity. 37:463–474. 2012. View Article : Google Scholar
7	Wong SH, Walker JA, Jolin HE, Drynan LF, Hams E, Camelo A, Barlow JL, Neill DR, Panova V, Koch U, et al: Transcription factor RORα is critical for nuocyte development. Nat Immunol. 13:229–236. 2012. View Article : Google Scholar :
8	Mjösberg JM, Trifari S, Crellin NK, Peters CP, Van Drunen CM, Piet B, Fokkens WJ, Cupedo T and Spits H: Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 12:1055–1062. 2011. View Article : Google Scholar
9	Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, et al: Innate lymphoid cells promote lung-tissue homeostasis following infection with influenza virus. Nat Immunol. 12:1045–1054. 2011. View Article : Google Scholar :
10	Trikha P and Carson WE III: Signaling pathways involved in MDSC regulation. Biochim Biophys Acta. 1846:55–65. 2014.
11	Mantovani A: The growing diversity and spectrum of action of myeloid-derived suppressor cells. Eur J Immunol. 40:3317–3320. 2010. View Article : Google Scholar
12	Khaled YS, Ammori BJ and Elkord EJ: Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. Immunol Res. 2014:8798972014.
13	Gabrilovich DI and Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar :
14	Feng PH, Lee KY, Chang YL, Chan YF, Kuo LW, Lin TY, Chung FT, Kuo CS, Yu CT, Lin SM, et al: CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer. Am J Respir Crit Care Med. 186:1025–1036. 2012. View Article : Google Scholar :
15	Heuvers ME, Muskens F, Bezemer K, Lambers M, Dingemans AM, Groen HJ, Smit EF, Hoogsteden HC, Hegmans JP and Aerts JG: Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients. Lung Cancer. 81:468–474. 2013. View Article : Google Scholar
16	Ortiz ML, Lu L, Ramachandran I and Gabrilovich DI: Myeloid- derived suppressor cells in the development of lung cancer. Cancer Immunol Res. 2:50–58. 2014. View Article : Google Scholar
17	Gabrilovich D: Mechanisms and functional significance of tumor-induced dendritic-cell defects. Nat Rev Immunol. 4:941–952. 2004. View Article : Google Scholar
18	Bronte V, Serafini P, Apolloni E and Zanovello P: Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J Immunother. 24:431–446. 2001. View Article : Google Scholar
19	Sinha P, Clements VK and Ostrand-Rosenberg S: Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J Immunol. 174:636–645. 2005. View Article : Google Scholar
20	Kusmartsev SA, Li Y and Chen SH: Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol. 165:779–785. 2000. View Article : Google Scholar
21	Bie Q, Zhang P, Su Z, Zheng D, Ying X, Wu Y, Yang H, Chen D, Wang S and Xu H: Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer. J Immunol Res. 2014:9231352014. View Article : Google Scholar :
22	Xu Y, Gao J, Su Z, Dai X, Li Y, Liu Y, Chen J, Tong J, Zhang Y, Wu C, et al: Down regulation of Hlx closely related to the decreased expressions of T-bet and Runx3 in patients with gastric cancer may be associated with a pathological event leading to the imbalance of Th1/Th2. Clin Dev Immunol. 2012:9498212012. View Article : Google Scholar :
23	Sobin LH and Compton CC: TNM seventh edition: What's new, what's changed: Communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar
24	Halim TY, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie AN and Takei F: Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity. 40:425–435. 2014. View Article : Google Scholar :
25	Matthew T, Melissa H, Shinji T, Dawn C, Kasia G, Kelli B, Marc Q, Martin L, Tina V, Kelli B, et al: Respiratory syncytial virus infection activates IL-13-producing group 2 innate lyphoid cells through thymic stromal lymphopoietin. J Allergy Clin Immunol. 138:814–824.e11. 2016. View Article : Google Scholar :
26	Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, et al: Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 464:1367–1370. 2010. View Article : Google Scholar :
27	Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH and Umetsu DT: Innate lymphoid cells mediate influenza-induced airway hyperreactivity independently of adaptive immunity. Nat Immunol. 12:631–638. 2011. View Article : Google Scholar :
28	Shaw JL, Fakhri S, Citardi MJ, Porter PC, Corry DB, Kheradmand F, Liu YJ and Luong A: IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosi-nusitis with nasal polyps. Am J Respir Crit Care Med. 188:432–439. 2013. View Article : Google Scholar
29	Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, et al: Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol. 13:145–149. 2013. View Article : Google Scholar
30	Reppert S, Boross I, Koslowski M, Türeci Ö, Koch S, Lehr HA and Finotto S: A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer. Nat Commun. 2:6002011. View Article : Google Scholar
31	Wan YY: GATA3: A master of many trades in immune regulation. Cell. 35:233–242. 2014.
32	Gabitass RF, Annels NE, Stocken DD, Pandha HA and Middleton GW: Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immonol Immunother. 60:1419–1430. 2011. View Article : Google Scholar
33	Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R, Taylor PA, Panoskaltsis-Mortari A, Serody JS, Munn DH, et al: Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is upregulated by interleukin-13. Blood. 116:5738–5747. 2010. View Article : Google Scholar :
34	Van Ginderachter JA, Beschin A, De Baetselier P and Raes G: Myeloid-derived suppressor cells in parasitic infections. Eur J Immunol. 40:2976–2985. 2010. View Article : Google Scholar
35	Wu Y, Yan Y, Su Z, Bie Q, Wu J, Wang S, Yu Y, Ding H, Lu P and Xu H: Enhanced circulating ILC2s accompany by upregulated MDSCs in patients with asthma. Int J Clin Exp Pathol. 8:3568–3579. 2015.
36	Wolterink RG Klein, Serafini N, Van Nimwegen M, Vosshenrich CA, de Bruijn MJ, Pereira D Fonseca, Fernandes H Veiga, Hendriks RW and Di Santo JP: Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc Natl Acad Sci USA. 110:pp. 10240–10245. 2013; View Article : Google Scholar :
37	Bando JK, Nussbaum JC, Liang HE and Locksley RM: Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inlamed lung. J Leukoc Biol. 94:877–884. 2013. View Article : Google Scholar :